Chongqing Zhifei Bio Products Net Asset Quality Index
Chongqing Zhifei Bio Products net asset quality index. Chongqing Zhifei Bio Products (300122) has a Net Asset Quality Index of 54.9% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥27.82 Billion minus total liabilities of CN¥12.53 Billion yields net assets of CN¥15.29 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check Chongqing Zhifei Bio Products (300122) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Chongqing Zhifei Bio Products (2007–2025)
Net asset quality index of Chongqing Zhifei Bio Products from 2007 to 2025. This chart shows how Chongqing Zhifei Bio Products's Net Asset Quality Index has evolved across 19 annual periods from 2007 to 2025. As of June 2026, the index stands at 54.9%, representing net assets of CN¥15.29 Billion against total assets of CN¥27.82 Billion CNY. See Chongqing Zhifei Bio Products book value and equity for net asset value and shareholders' equity analysis.
Chongqing Zhifei Bio Products Net Asset Quality Index by Year (2007–2025)
Chongqing Zhifei Bio Products net asset quality index by year from 2007 to 2025. The table below presents the year-by-year Net Asset Quality Index for Chongqing Zhifei Bio Products from 2007 to 2025, covering 19 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market cap of Chongqing Zhifei Bio Products.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 50.8% | CN¥16.11 Billion | CN¥31.72 Billion | CN¥15.61 Billion | ▼ -11.0 pp |
| 2024 | 61.8% | CN¥30.83 Billion | CN¥49.91 Billion | CN¥19.08 Billion | ▼ -0.9 pp |
| 2023 | 62.7% | CN¥31.51 Billion | CN¥50.23 Billion | CN¥18.73 Billion | ▼ -1.1 pp |
| 2022 | 63.8% | CN¥24.24 Billion | CN¥38.00 Billion | CN¥13.77 Billion | ▲ +5.0 pp |
| 2021 | 58.8% | CN¥17.66 Billion | CN¥30.05 Billion | CN¥12.39 Billion | ▲ +4.6 pp |
| 2020 | 54.2% | CN¥8.25 Billion | CN¥15.22 Billion | CN¥6.97 Billion | ▲ +1.7 pp |
| 2019 | 52.5% | CN¥5.75 Billion | CN¥10.94 Billion | CN¥5.20 Billion | ▼ -8.9 pp |
| 2018 | 61.4% | CN¥4.18 Billion | CN¥6.81 Billion | CN¥2.63 Billion | ▼ -10.2 pp |
| 2017 | 71.5% | CN¥2.94 Billion | CN¥4.11 Billion | CN¥1.17 Billion | ▼ -21.5 pp |
| 2016 | 93.1% | CN¥2.52 Billion | CN¥2.71 Billion | CN¥188.21 Million | ▲ +1.0 pp |
| 2015 | 92.1% | CN¥2.47 Billion | CN¥2.68 Billion | CN¥212.40 Million | ▲ +1.5 pp |
| 2014 | 90.5% | CN¥2.46 Billion | CN¥2.71 Billion | CN¥256.72 Million | ▼ -1.8 pp |
| 2013 | 92.3% | CN¥2.39 Billion | CN¥2.59 Billion | CN¥198.61 Million | ▼ -2.5 pp |
| 2012 | 94.8% | CN¥2.37 Billion | CN¥2.50 Billion | CN¥130.53 Million | ▲ +0.9 pp |
| 2011 | 93.9% | CN¥2.26 Billion | CN¥2.40 Billion | CN¥146.22 Million | ▼ -3.0 pp |
| 2010 | 96.9% | CN¥2.14 Billion | CN¥2.21 Billion | CN¥67.59 Million | ▲ +9.7 pp |
| 2009 | 87.2% | CN¥451.69 Million | CN¥518.02 Million | CN¥66.33 Million | ▲ +18.7 pp |
| 2008 | 68.5% | CN¥267.06 Million | CN¥390.10 Million | CN¥123.05 Million | ▲ +11.9 pp |
| 2007 | 56.6% | CN¥188.03 Million | CN¥332.30 Million | CN¥144.27 Million | — |